Everolimus

Everolimus is a small molecule which can act as a mTOR inhibitor. It is provided as a powder.

This product acts on the following target types: Kinase.
This product acts on the following biochemical pathways: mTOR.
This product may be of interest in the following research areas and diseases: Immunology, Cancer, Diabetes.
This product may act as a Coronavirus inhibitor: Inhibits SARS-CoV in silico, and MERS-CoV in cells.

Please note that our chemical products are for scientific research use only and are not for medical or veterinary use. This product can only be dispatched to a scientific business or laboratory address.

Target	Everolimus
Form	Solid
Purity	≥ 98% (HPLC). Conforms to structure by NMR.
Reconstitution	Soluble in DMSO (up to 100 mg/ml) or in Ethanol (up to 100 mg/ml).
Storage	Store desiccated at -20 °C.
Molecular Weight	956.2 g/mol
Molecular Formula	C53H83NO14
Buffer	Not applicable.
CAS Number	159351-69-6
Availability	Shipped within 5-10 working days.
Note	This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use.

Research Articles on Everolimus

Write a review

Your Name

Your Email Address

PMID

DOI

Your Review

Rating

Continue